Human thyroid tumours, the puzzling lessons from E7 and RET/PTC3 transgenic mice

British Journal of Cancer

Volumn 99, Issue 11, 2008, Pages 1874-1883

  Jin, L ^a   Burniat, A ^a   Dumont, J E ^a   Miot, F ^a   Corvilain, B ^a   Franc, B ^b  

^a UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

^b LABORATOIRE DES SCIENCES DU CLIMAT ET DE L ENVIRONNEMENT   (France)

Author keywords

Cribriform patterns in thyroid tumour; Papillary thyroid carcinoma; RET PTC3 and E7 transgenic mice

Indexed keywords

MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN KINASE B;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CARCINOGENICITY; CELL PROLIFERATION; CONTROLLED STUDY; GENE EXPRESSION; GOITER; IMMUNOHISTOCHEMISTRY; MOUSE; NONHUMAN; OVARY FOLLICLE CELL; PAPILLARY CARCINOMA; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; THYROID CARCINOMA; THYROID FUNCTION; TUMOR GROWTH;

EID: 56749152359     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/sj.bjc.6604740     Document Type: Article

References (53)

1. Anwar F, Emond MJ, Schmidt RA, Hwang HC, Bronner MP (2000) Retinoblastoma expression in thyroid neoplasms. Mod Pathol 13(5): 562-569
2. Basolo F, Giannini R, Monaco C, Melillo RM, Carlomagno F, Pancrazi M, Salvatore G, Chiappetta G, Pacini F, Elisei R, Miccoli P, Pinchera A, Fusco A, Santoro M (2002) Potent mitogenicity of the RET/PTC 3 oncogene correlates with its prevalence in tall-cell variant of papillary thyroid carcinoma. Am J Pathol 160(1): 247-254
3. Baverstock K, Egloff B, Pinchera A, Ruchti C, Williams D (1992) Thyroid cancer after Chenobyl. Nature 359: 21-22
4. Brandwein-Gensler MS, Wang BY, Urken ML (2004) Spindle cell transformation of papillary carcinoma: an aggressive entity distinct from anaplastic thyroid carcinoma. Arch Pathol Lab Med 128(1): 87-89
5. Bronner MP, LiVolsi VA (1991) Spindle cell squamous carcinoma of the thyroid: an unusual anaplastic tumor associated with tall cell papillary cancer. Mod Pathol 4(5): 637-643
6. Brunet A, Bonni A, Zigmond MJ, Lin MZ, Juo P, Hu LS, Anderson MJ, Arden KC, Blenis J, Greenberg ME (1999) Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor. Cell 96(6): 857-868
7. Burniat A, Jin L, Detours V, Driessens N, Goffard JC, Santoro M, Rothstein J, Dumont JE, Miot F, Corvilain B (2008) Gene expression in RET/PTC3 and E7 transgenic mouse thyroids: RET/PTC3 but not E7 tumors are partial and transient models of human papillary thyroid cancers. Endocrinology 149: 5107-5117
8. Cetta F, Pelizzo MR, Curia MC, Barbarisi A (1999) Genetics and clinicopathological findings in thyroid carcinomas associated with familial adenomatous polyposis. Am J Pathol 155(1): 7-9
9. Cho JY, Sagartz JE, Capen CC, Mazzaferri EL, Jhiang SM (1999) Early cellular abnormalities induced by RET/PTC1 oncogene in thyroid-targeted transgenic mice. Oncogene 18(24): 3659-3665
10. Chow SM, Chan JK, Law SC, Tang DL, Ho CM, Cheung WY, Wong IS, Lau WH. (2003) Diffuse sclerosing variant of papillary thyroid carcinoma - clinical features and outcome. Eur J Surg oncol 29: 446-449
11. Coppée F, Depoortere F, Bartek J, Ledent C, Parmentier M, Dumont JE (1998) Differential patterns of cell cycle regulatory proteins expression in transgenic models of thyroid tumours. Oncogene 17: 631-641
12. Coppée F, Gérard AC, Denef JF, Ledent C, Vassart G, Dumont JE, Parmentier M (1996) Early occurrence of metastatic differentiated thyroid carcinomas in transgenic mice expressing the A2a adenosine receptor gene and the human papillomavirus type 16 E7 oncogene. Oncogene 13: 1471-1482
13. Coulonval K, Maenhaut C, Dumont JE, Lamy F (1997) Phosphorylation of the three Rb protein family members is a common step of the cAMP-, the growth factor, and the phorbol ester-mitogenic cascades but is not necessary for the hypertrophy induced by insulin. Exp Cell Res 233(2): 395-398
14. Dumont JE, Jauniaux JC, Roger PP (1989) The cyclic AMP-mediated stimulation of cell proliferation. Trends Biochem Sci 15(2): 67-71
15. Dumont JE, Maenhaut C, Christophe D, Vassart G, Roger PP (2005) The phylogeny, ontogeny, anatomy and regulation of the iodine metabolizing thyroid. Thyroid disease manager chapter 1: 1-76
16. Dyson N (1998) The regulation of E2F by pRB-family proteins. Genes 12: 2245-2262
17. Fagin JA (2002) Minireview: branded from the start-distinct oncogenic initiating events may determine tumor fate in the thyroid. Mol Endocrinol 16(5): 903-911
18. Franc B, Ledent C, de Saint-Maur PP, Parmentier M (1998) Thyroid insular carcinoma. Arch Anat Cytol Pathol 46(1-2): 63-78
19. Fusco A, Chiappetta G, Hui P, Garcia-Rostan G, Golden L, Kinder BK, Dillon DA, Giuliano A, Cirafici AM, Santoro M, Rosai J, Tallini G (2002) Assessment of RET/PTC oncogene activation and clonality in thyroid nodules with incomplete morphological evidence of papillary carcinoma: a search for the early precursors of papillary cancer. Am J Pathol 160(6): 1941-1944
20. Gérard AC, Daumerie C, Mestdagh C, Gohy S, De Burbure C, Costagliola S, Miot F, Nollevaux MC, Denef JF, Rahier J, Franc B, De Vijlder JJ, Colin IM, Many MC (2003) Correlation between the loss of thyroglobulin iodinated and the expression of thyroid-specific proteins involved in iodine metabolism in thyroid carcinomas. J Clin Endocrinol Metabol 88(10): 4977-4983
21. Harach HR, Williams GT, Williams ED (1994) Familial adenomatous polyposis associated thyroid carcinoma: a distinct type of follicular cell neoplasm. Histopathology 25(6): 549-561
22. Helin K (1998) Regulation of cell proliferation by the E2F transcription factors. Curr Opin Genet 8: 28-35
23. Iuliano R, Trapasso F, Stella A, Le pira I, Melillo RM, Bruni P, Baldassarre G, Chiariotti L, Santoro M, Viglietto G, Fusco A (2000) Pivotal role of the RB family proteins in in vitro thyroid cells transformation. Exp Cell Res 260: 257-267
24. Jhiang SM, Sagartz JE, Tong Q, Parker-Thornburg J, Capen CC, Cho JY, Xing S, Ledent C (1996) Targeted expression of the ret/PTC1 oncogene induces papillary thyroid carcinomas. Endocrinology 137(1): 375-378
25. Kasakov VS, Demidchik EP, Astakhova LN (1992) Thyroid cancer after Chernobyl. Nature 359: 21
26. Knostman KA, Jhiang SM, Capen CC (2007) Genetic alterations in thyroid cancer: the role of mouse models. Vet Pathol 44(1): 1-14
27. La Perle KM, Jhiang SM, Capen CC (2000) Loss of p53 promotes anaplasia and local invasion in ret/PTC1-induced thyroid carcinomas. Am J Pathol 157(2): 671-677
28. Ledent C (1996) Transgenic models of human thyeoid pathologies: hyperfunctional adenoma, anaplastic cancer, differentiated cancer, hypothyroidism. Bull Mem Acad R Med Belg 151(2): 195-201
29. Ledent C, Marcotte A, Dumont JE, Vassart G, Parmentier M (1995) Differentiated carcinomas develop as a consequence of the thyeoid specific expression of a thyroglobulin-human papillomavirus type 16 E7 transgene. Oncogene 10(9): 1789-1797
30. Melillo RM, Castellone MD, Guarino V, De Falco V, Cirafici AM, Salvatore G, Caiazzo F, Basolo F, Giannini R, Kruhoffer M, Orntoft T, Fusco A, Santoro M (2005) The RET/PTC-RAS-BRAF linear signaling cascade mediates the motile and mitogenic phenotype of thyroid cancer cells. J Clin Invest 115(4): 1068-1081
31. Mitsutake N, Miyagishi M, Mitsutake S, Akeno N, Mesa Jr C, Knauf JA, Zhang L, Taira K, Fagin JA (2006) BRAF mediates RET/PTC-induced mitogen-activated protein kinase activation in thyroid cells: functional support for requirement of the RET/PTC-RAS-BRAF pathway in papillary thyroid carcinogenesis. Endocrinology 147(2): 1014-1019
32. Münger K, Werness BA, Dyson N, Phelps WC, Harlow E, Howley PM (1989) Complex formation of human papillomavirus E7 proteins with the retinoblastoma tumor suppressor gene product. EMBO J 8(13): 4099-4105
33. Nakazawa T, Kondo T, Kobayashi Y, Takamura N, Murata S, Kameyama K, Muramatsu A, Ito K, Kobayashi M, Katoh R (2005) RET gene rearrangements (RET/PTC1 and RET/PTC3) in papillary thyroid carcinomas from an iodine-rich country (Japan). Cancer 104(5): 943-951
34. Nikiforov YE, Rowland JM, Bove KE, Monforte-Munoz H, Fagin JA (1997) Distinct pattern of ret oncogene rearrangements in morphological variants of radiation-induced and sporadic thyroid papillary carcinomas in children. Cancer Res 57(9): 1690-1694
35. Portella G, Borselli C, Santoro M, Gerbasio D, D'Armiento MR, Dumont JE, Ledent C, Rothstein JL, Vecchio G, Fusco A (2000) Human papilloma virus 16 E7 oncogene does not cooperate with RET/PTC3 oncogene in the neoplastic transformation of thyroid cells in the transgenic mice. Oncol Res 12: 347-354
36. Powell Jr DJ, Russell J, Nibu K, Li G, Rhee E, Liao M, Goldstein M, Keane WM, Santoro M, Fusco A, Rothstein JL (1998) The RET/PTC3 oncogene: metastatic solid-type papillary carcinomas in murine thyroids. Cancer res 58: 5523-5528
37. Powell Jr DJ, Russell JP, Li G, Kuo BA, Fidanza V, Huebner K, Rothstein JL (2001) Altered gene expression in immunogenic poorly differentiated thyroid carcinomas from RET/PTC3p53-/-. Oncogene 20: 3235-3246
38. Riesco-Eizaguirre G, Santisteban P (2006) A perspective view of sodium iodide symporter research and its clinical implications. Eur J Endocrinol 155(4): 495-512
39. Russell JP, Engiles JB, Rothstein JL (2004) Proinflammatory mediators and genetic background in oncogene mediated tumor progression. J Immunol 172(7): 4059-4067
40. Russell JP, Powell DJ, Cunnane M, Greco A, Portella G, Santoro M, Fusco A, Rothstein JL (2000) The TRK-T1 fusion protein induces neoplastic transformation of thyroid epithelium. Oncogene 19(50): 5729-5735
41. Sagartz JE, Jhiang SM, Tong Q, Capen CC (1997) Thyroid-stimulating hormone promotes growth of thyroid carcinomas in transgenic mice with targeted expression of the ret/PTC1 oncogene. Lab Invest 76(3): 307-318
42. Saito T, Endo T, Kavaguchi A, Ikeda M, Katoh R, Kawaoi A, Muramatsu A, Onaya T (1998) Increased expression of sodium/iodide symporter in papillary thyroid carcinomas. J Clin Invest 101: 1296-1300
43. Santoro M, Melillo RM, Carlomagno F, Fusco A, Vecchio G (2002) Molecular mechanisms of RET activation in human cancer. Ann N Y Acad Sci 963: 116-121
44. Santoro M, Melillo RM, Fusco A (2006) RET/PTC activation in papillary thyroid carcinoma: European Journal of Endocrinology Prize Lecture. Eur J Endocrinol 155(5): 645-653
45. Soravia C, Sugg SL, Berk T, Mitri A, Cheng H, Gallinger S, Cohen Z, Asa SL, Bapat BV (1999) Familial adenomatous polyposis-associated thyroid cancer: a clinical, pathological, and molecular genetics study. Am J Pathol 154(1): 127-135
46. Thomas GA, Bunnell H, Cook HA, Williams ED, Nerovnya A, Cherstvoy ED, Tronko ND, Bogdanova TI, Chiappetta A, Viglietto G, Pentimalli F, Salvatore G, Fusco A, Santoro M, Vecchio G (1999) High prevalence of ret/PTC rearrangements in Ukrainian and Belarussian post-Chernobyl thyroid papillary carcinomas: a strong correlation between ret/PTC3 and the solid-follicular variant. J Clin Endocrinol Metab 84: 4232-4238
47. Trouttet-Masson S, Selmi-Ruby S, Bernier-Valentin F, Porra V, Berger-Dutrieux N, Decaussin M, Peix JL, Perrin A, Bournaud C, Orgiazzi J, Borson-Chazot F, Franc B, Rousset B (2004) Evidence for transcriptional and posttranscriptional alterations of the sodium/iodide symporter expression in hypofunctioning benign and malignant thyroid tumors. Am J Pathol 165(1): 25-34
48. Vergilio J, Baloch ZW, LiVolsi VA (2002) Spindle cell metaplasia of the thyroid arising in association with papillary carcinoma and follicular adenoma. Am J Clin Pathol 117(2): 199-204
49. Wang S, Lloyd RV, Hutzler MJ, Safran MS, Patwardhan NA, Khan A (2000) The role of cell cycle regulatory protein, cyclin D1, in the progression of thyroid cancer. Mod Pathol 13(8): 882-887
50. Wapnir IL, van de Rijn M, Nowels K, Amenta PS, Walton K, Montgomery K, Greco RS, Dohán O, Carrasco N (2003) Immunohistochemical profile of the sodium/iodide symporter in thyroid, breast, and other carcinomas using high density tissue microarrays and conventional sections. J Clin Endocrinol Metab 88(4): 1880-1888
51. Weinberg RA (1995) The retinoblastoma protein and cell cycle control. Cell 81(3): 323-330
52. Wenig BM, Thompson LD, Adair CF, Shmookler B, Heffess CS (1998) Thyroid papillary carcinoma of columnar cell type, a clinico pathologic study of 16 cases. Cancer 82: 740-753
53. Williams ED (1994) Thyroid tumorigenesis. Horm Res 42(1-2): 31-34